Health care is shaping up to be one of the top issues of the 2020 presidential race. And with tens of thousands of Americans losing their health insurance to a coronavirus-induced recession, fears of inadequate or nonexistent health care coverage have never been greater. People ask, “Where am I going to get health insurance and how much is it going to cost me?” Each presidential candidate offers a very different view of the future of healthcare. President Trump promised to “come up with a great health plan,” one that would repeal the Affordable Care Act but replace it with something better while maintaining its biggest selling point: protecting people with pre-existing medical conditions. Joe Biden is pushing to build and expand on the Affordable Care Act. As for the COVID pandemic, Biden's proposals emphasize the role of the federal government leading the response, while Trump has delegated much to the states. What’s in store for the future? Join MIT’s Jonathan Gruber, Professor of Economics, for an interview on the Future of Healthcare After the Election.
Sustainable and scalable processes in mining and metal transformation are key to responding to the climate change challenges of the 21stcentury. Join MIT researchers and MIT spun-out startups to hear the latest research on Resources Extraction Technologies, and what future trends we can expect in the metal processing industry.
Tailings – what’s left after mined ores are fully processed – is today a global liability. But there are tens of billions of dollars of material value tied up in those tailings. Why not turn them into a revenue opportunity? MIT researchers, and newly spun-out startup companies, are hard at work on inventing, developing, and scaling up technologies that will enable this transition. Join us on November 18th to learn more about this impactful work!
Over the past decade, research on the development of multi-cellular engineered living systems has produced technologies and capabilities that are now positioned to facilitate a fundamental understanding of disease processes and can help to identify innovative therapeutic strategies. Globally, while many labs are engaged in the development of new and more sophisticated organ models for drug discovery and screening, there is an urgent need to disrupt the way drugs are currently developed. Our vision is to humanize drug development based on a new approach that integrates microphysiological system models of disease and enhanced model control/interrogation, with modern systems biology and systems immunology. This is the focus of Living Machines, one of five threads in the New Engineering Education Transformation (NEET) program to reimagine engineering education at MIT in which sophomores, juniors and seniors, under the guidance of faculty mentors and instructors, learn, discover, build and engineer living systems for broad applications in biotechnology and medical devices. This webinar will share the perspectives of 3 MIT faculty, their research capabilities and interests in which NEET students can participate, and that of several NEET students and what they can or hope to achieve.